The effect of chronic stress on anti-angiogenesis of sunitinib in colorectal cancer models

Psychoneuroendocrinology

Volumn 52, Issue 1, 2015, Pages 130-142

  Liu, Jie ^a   Deng, Guo Hua ^a   Zhang, Jie ^a   Wang, Ying ^a   Xia, Xiang Yu ^a   Luo, Xin Mei ^a   Deng, Yao Tiao ^a   He, Sha Sha ^a   Mao, Yin Yan ^a   Peng, Xing Chen ^a   Wei, Yu Quan ^a   Jiang, Yu ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Adrenoceptor; Anti angiogenic therapy; Chronic stress; Norepinephrine; Sunitinib

Indexed keywords

BETA ADRENERGIC RECEPTOR; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; INTERLEUKIN 8; NORADRENALIN; PROPRANOLOL; SUNITINIB; VASCULOTROPIN; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ANGIOGENESIS INHIBITOR; IL8 PROTEIN, HUMAN; INDOLE DERIVATIVE; PYRROLE DERIVATIVE; VASCULOTROPIN A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CHRONIC STRESS; CLINICAL EFFECTIVENESS; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MENTAL STRESS; MOUSE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR GROWTH; TUMOR VOLUME; UPREGULATION; ANIMAL; BAGG ALBINO MOUSE; CHRONIC DISEASE; COLORECTAL NEOPLASMS; DISEASE MODEL; METABOLISM; TUMOR CELL LINE;

ADRENERGIC ALPHA-AGONISTS; ANGIOGENESIS INHIBITORS; ANIMALS; CELL LINE, TUMOR; CHRONIC DISEASE; COLORECTAL NEOPLASMS; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; INDOLES; INTERLEUKIN-8; MICE; MICE, INBRED BALB C; NOREPINEPHRINE; PYRROLES; RECEPTORS, ADRENERGIC, BETA; SIGNAL TRANSDUCTION; STRESS, PSYCHOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84922683289     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2014.11.008     Document Type: Article

References (51)

1. Beloeil H., Mazoit J.X., Benhamou D., Duranteau J. Norepinephrine kinetics and dynamics in septic shock and trauma patients. Br. J. Anaesth. 2005, 95:782-788.
2. Broutin S., Ameur N., Lacroix L., Robert T., Petit B., Oumata N., Talbot M., Caillou B., Schlumberger M., Dupuy C., Bidart J.M. Identification of soluble candidate biomarkers of therapeutic response to sunitinib in medullary thyroid carcinoma in preclinical models. Clin. Cancer Res. 2011, 17:2044-2054.
3. Brown K.W., Levy A.R., Rosberger Z., Edgar L. Psychological distress and cancer survival: a follow-up 10 years after diagnosis. Psychosom. Med. 2003, 65:636-643.
4. Burkitt K., Chun S.Y., Dang D.T., Dang L.H. Targeting both HIF-1 and HIF-2 in human colon cancer cells improves tumor response to sunitinib treatment. Mol. Cancer Ther. 2009, 8:1148-1156.
5. Chetty S., Friedman A.R., Taravosh-Lahn K., Kirby E.D., Mirescu C., Guo F., Krupik D., Nicholas A., Geraghty A.C., Krishnamurthy A., Tsai M.K., Covarrubias D., Wong A.T., Francis D.D., Sapolsky R.M., Palmer T.D., Pleasure D., Kaufer D. Stress and glucocorticoids promote oligodendrogenesis in the adult hippocampus. Mol. Psychiatr. 2014, 19:1275-1283.
6. Christensen J.G. A preclinical review of sunitinib, a multitargeted receptor tyrosine kinase inhibitor with anti-angiogenic and antitumour activities. Ann. Oncol. 2007, 18(Supplement 10):x3-x10.
7. Christiansen S.H., Olesen M.V., Wortwein G., Woldbye D.P. Fluoxetine reverts chronic restraint stress-induced depression-like behaviour and increases neuropeptide Y and galanin expression in mice. Behav. Brain Res. 2011, 216:585-591.
8. Crema L., Schlabitz M., Tagliari B., Cunha A., Simao F., Krolow R., Pettenuzzo L., Salbego C., Vendite D., Wyse A.T., Dalmaz C. Na+, K+ ATPase activity is reduced in amygdala of rats with chronic stress-induced anxiety-like behavior. Neurochem. Res. 2010, 35:1787-1795.
9. Deng G.H., Liu J., Zhang J., Wang Y., Peng X.C., Wei Y.Q., Jiang Y. Exogenous norepinephrine attenuates the efficacy of sunitinib in a mouse cancer model. J. Exp. Clin. Cancer Res. 2014, 33:21.
10. Deng Y.T., Zhong W.N., Jiang Y. Measurement of distress and its alteration during treatment in patients with nasopharyngeal carcinoma. Head Neck 2014, 36:1077-1086.
11. Fan F., Wey J.S., McCarty M.F., Belcheva A., Liu W., Bauer T.W., Somcio R.J., Wu Y., Hooper A., Hicklin D.J., Ellis L.M. Expression and function of vascular endothelial growth factor receptor-1 on human colorectal cancer cells. Oncogene 2005, 24:2647-2653.
12. Frick L.R., Arcos M.L., Rapanelli M., Zappia M.P., Brocco M., Mongini C., Genaro A.M., Cremaschi G.A. Chronic restraint stress impairs T-cell immunity and promotes tumor progression in mice. Stress 2009, 12:134-143.
13. Furuta A., Funahashi H., Sawai H., Sato M., Okada Y., Takeyama H., Manabe T. The relationship between GDNF and integrins in human colorectal cancer cell activity. Hepatogastroenterology 2007, 54:1398-1402.
14. Giorgi E.E., Bhattacharya T. A note on two-sample tests for comparing intra-individual genetic sequence diversity between populations. Biometrics 2012, 68:1323-1326. (author reply 1326).
15. Gordon M.S., Mendelson D.S., Kato G. Tumor angiogenesis and novel antiangiogenic strategies. Int. J. Cancer 2010, 126:1777-1787.
16. Li A., Dubey S., Varney M.L., Dave B.J., Singh R.K. IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis. J. Immunol. 2003, 170:3369-3376.
17. Li G., Tian L., Hou J.M., Ding Z.Y., He Q.M., Feng P., Wen Y.J., Xiao F., Yao B., Zhang R., Peng F., Jiang Y., Luo F., Zhao X., Zhang L., Zhou Q., Wei Y.Q. Improved therapeutic effectiveness by combining recombinant CXC chemokine ligand 10 with cisplatin in solid tumors. Clin. Cancer Res. 2005, 11:4217-4224.
18. Lin Q., Wang F., Yang R., Zheng X., Gao H., Zhang P. Effect of chronic restraint stress on human colorectal carcinoma growth in mice. PLoS One 2013, 8:e61435.
19. Lutgendorf S.K., Cole S., Costanzo E., Bradley S., Coffin J., Jabbari S., Rainwater K., Ritchie J.M., Yang M., Sood A.K. Stress-related mediators stimulate vascular endothelial growth factor secretion by two ovarian cancer cell lines. Clin. Cancer Res. 2003, 9:4514-4521.
20. Masur K., Niggemann B., Zanker K.S., Entschladen F. Norepinephrine-induced migration of SW 480 colon carcinoma cells is inhibited by beta-blockers. Cancer Res. 2001, 61:2866-2869.
21. Mendel D.B., Laird A.D., Xin X., Louie S.G., Christensen J.G., Li G., Schreck R.E., Abrams T.J., Ngai T.J., Lee L.B., Murray L.J., Carver J., Chan E., Moss K.G., Haznedar J.O., Sukbuntherng J., Blake R.A., Sun L., Tang C., Miller T., Shirazian S., McMahon G., Cherrington J.M. In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: determination of a pharmacokinetic/pharmacodynamic relationship. Clin. Cancer Res. 2003, 9:327-337.
22. Mitchell A.J., Ferguson D.W., Gill J., Paul J., Symonds P. Depression and anxiety in long-term cancer survivors compared with spouses and healthy controls: a systematic review and meta-analysis. Lancet Oncol. 2013, 14:721-732.
23. Mologni L. Development of RET kinase inhibitors for targeted cancer therapy. Curr. Med. Chem. 2011, 18:162-175.
24. Nakane T., Szentendrei T., Stern L., Virmani M., Seely J., Kunos G. Effects of IL-1 and cortisol on beta-adrenergic receptors, cell proliferation, and differentiation in cultured human A549 lung tumor cells. J. Immunol. 1990, 145:260-266.
25. Ning Y., Manegold P.C., Hong Y.K., Zhang W., Pohl A., Lurje G., Winder T., Yang D., LaBonte M.J., Wilson P.M., Ladner R.D., Lenz H.J. Interleukin-8 is associated with proliferation, migration, angiogenesis and chemosensitivity in vitro and in vivo in colon cancer cell line models. Int. J. Cancer 2011, 128:2038-2049.
26. Oros-Pantoja R., Jarillo-Luna A., Rivera-Aguilar V., Sanchez-Torres L.E., Godinez-Victoria M., Campos-Rodriguez R. Effects of restraint stress on NALT structure and nasal IgA levels. Immunol. Lett. 2011, 135:78-87.
27. Palesh O., Butler L.D., Koopman C., Giese-Davis J., Carlson R., Spiegel D. Stress history and breast cancer recurrence. J. Psychosom. Res. 2007, 63:233-239.
28. Palm D., Lang K., Niggemann B., Drell T.L.t.Masur K., Zaenker K.S., Entschladen F. The norepinephrine-driven metastasis development of PC-3 human prostate cancer cells in BALB/c nude mice is inhibited by beta-blockers. Int. J. Cancer 2006, 118:2744-2749.
29. Pike J.L., Smith T.L., Hauger R.L., Nicassio P.M., Patterson T.L., McClintick J., Costlow C., Irwin M.R. Chronic life stress alters sympathetic, neuroendocrine, and immune responsivity to an acute psychological stressor in humans. Psychosom. Med. 1997, 59:447-457.
30. Pilipovic I., Radojevic K., Perisic M., Kosec D., Nacka-Aleksic M., Djikic J., Leposavic G. Catecholaminergic signalling through thymic nerve fibres, thymocytes and stromal cells is dependent on both circulating and locally synthesized glucocorticoids. Exp. Physiol. 2012, 97:1211-1223.
31. Pirkmajer S., Chibalin A.V. Serum starvation: caveat emptor. Am. J. Physiol. Cell Physiol. 2011, 301:C272-C279.
32. Potapova O., Laird A.D., Nannini M.A., Barone A., Li G., Moss K.G., Cherrington J.M., Mendel D.B. Contribution of individual targets to the antitumor efficacy of the multitargeted receptor tyrosine kinase inhibitor SU11248. Mol. Cancer Ther. 2006, 5:1280-1289.
33. Roozendaal B., Hahn E.L., Nathan S.V., de Quervain D.J., McGaugh J.L. Glucocorticoid effects on memory retrieval require concurrent noradrenergic activity in the hippocampus and basolateral amygdala. J. Neurosci. 2004, 24:8161-8169.
34. Sapolsky R.M., Donnelly T.M. Vulnerability to stress-induced tumor growth increases with age in rats: role of glucocorticoids. Endocrinology 1985, 117:662-666.
35. Shahzad M.M., Arevalo J.M., Armaiz-Pena G.N., Lu C., Stone R.L., Moreno-Smith M., Nishimura M., Lee J.W., Jennings N.B., Bottsford-Miller J., Vivas-Mejia P., Lutgendorf S.K., Lopez-Berestein G., Bar-Eli M., Cole S.W., Sood A.K. Stress effects on FosB- and interleukin-8 (IL8)-driven ovarian cancer growth and metastasis. J. Biol. Chem. 2010, 285:35462-35470.
36. Skor M.N., Wonder E.L., Kocherginsky M., Goyal A., Hall B.A., Cai Y., Conzen S.D. Glucocorticoid receptor antagonism as a novel therapy for triple-negative breast cancer. Clin. Cancer Res. 2013, 19:6163-6172.
37. Sloan E.K., Priceman S.J., Cox B.F., Yu S., Pimentel M.A., Tangkanangnukul V., Arevalo J.M., Morizono K., Karanikolas B.D., Wu L., Sood A.K., Cole S.W. The sympathetic nervous system induces a metastatic switch in primary breast cancer. Cancer Res. 2010, 70:7042-7052.
38. Sood A.K., Bhatty R., Kamat A.A., Landen C.N., Han L., Thaker P.H., Li Y., Gershenson D.M., Lutgendorf S., Cole S.W. Stress hormone-mediated invasion of ovarian cancer cells. Clin. Cancer Res. 2006, 12:369-375.
39. Spiegel D. Mind matters in cancer survival. Psychooncology 2012, 21:588-593.
40. Tammela T., Enholm B., Alitalo K., Paavonen K. The biology of vascular endothelial growth factors. Cardiovasc. Res. 2005, 65:550-563.
41. Terme M., Pernot S., Marcheteau E., Sandoval F., Benhamouda N., Colussi O., Dubreuil O., Carpentier A.F., Tartour E., Taieb J. VEGFA-VEGFR pathway blockade inhibits tumor-induced regulatory T-cell proliferation in colorectal cancer. Cancer Res. 2013, 73:539-549.
42. Thaker P.H., Han L.Y., Kamat A.A., Arevalo J.M., Takahashi R., Lu C., Jennings N.B., Armaiz-Pena G., Bankson J.A., Ravoori M., Merritt W.M., Lin Y.G., Mangala L.S., Kim T.J., Coleman R.L., Landen C.N., Li Y., Felix E., Sanguino A.M., Newman R.A., Lloyd M., Gershenson D.M., Kundra V., Lopez-Berestein G., Lutgendorf S.K., Cole S.W., Sood A.K. Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat. Med. 2006, 12:939-944.
43. Thornton L.M., Andersen B.L., Blakely W.P. The pain, depression, and fatigue symptom cluster in advanced breast cancer: covariation with the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. Health Psychol. 2010, 29:333-337.
44. Valente M.M., Bortolotto V., Cuccurazzu B., Ubezio F., Meneghini V., Francese M.T., Canonico P.L., Grilli M. α2δ Ligands act as positive modulators of adult hippocampal neurogenesis and prevent depression-like behavior induced by chronic restraint stress. Mol. Pharmacol. 2012, 82:271-280.
45. Volden P.A., Conzen S.D. The influence of glucocorticoid signaling on tumor progression. Brain Behav. Immun. 2013, 30 Suppl:S26-S31.
46. Wang Y., Zou L., Jiang M., Wei Y., Jiang Y. Measurement of distress in Chinese inpatients with lymphoma. Psychooncology 2013, 22:1581-1586.
47. Watson M., Homewood J., Haviland J., Bliss J.M. Influence of psychological response on breast cancer survival: 10-year follow-up of a population-based cohort. Eur. J. Cancer 2005, 41:1710-1714.
48. Wu W.K., Wong H.P., Luo S.W., Chan K., Huang F.Y., Hui M.K., Lam E.K., Shin V.Y., Ye Y.N., Yang Y.H., Cho C.H. 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone from cigarette smoke stimulates colon cancer growth via beta-adrenoceptors. Cancer Res. 2005, 65:5272-5277.
49. Xiao D., Huang X., Bae S., Ducsay C.A., Longo L.D., Zhang L. Cortisol-mediated regulation of uterine artery contractility: effect of chronic hypoxia. Am. J. Physiol. Heart Circ. Physiol. 2004, 286:H716-H722.
50. Yang E.V., Kim S.J., Donovan E.L., Chen M., Gross A.C., Webster Marketon J.I., Barsky S.H., Glaser R. Norepinephrine upregulates VEGF, IL-8, and IL-6 expression in human melanoma tumor cell lines: implications for stress-related enhancement of tumor progression. Brain Behav. Immun. 2009, 23:267-275.
51. Yang E.V., Sood A.K., Chen M., Li Y., Eubank T.D., Marsh C.B., Jewell S., Flavahan N.A., Morrison C., Yeh P.E., Lemeshow S., Glaser R. Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells. Cancer Res. 2006, 66:10357-10364.